王寅雪, 尹毅青. 地佐辛联合不同药物对腹腔镜胃癌根治术后睡眠质量和早期恢复的影响[J]. 中国肿瘤临床, 2021, 48(20): 1036-1039. DOI: 10.12354/j.issn.1000-8179.2021.20210436
引用本文: 王寅雪, 尹毅青. 地佐辛联合不同药物对腹腔镜胃癌根治术后睡眠质量和早期恢复的影响[J]. 中国肿瘤临床, 2021, 48(20): 1036-1039. DOI: 10.12354/j.issn.1000-8179.2021.20210436
Yinxue Wang, Yiqing Yin. Effects of dezocine combined with different drugs on sleep quality and earlypostoperative recovery quality after laparoscopic resection of gastric cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 48(20): 1036-1039. DOI: 10.12354/j.issn.1000-8179.2021.20210436
Citation: Yinxue Wang, Yiqing Yin. Effects of dezocine combined with different drugs on sleep quality and earlypostoperative recovery quality after laparoscopic resection of gastric cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 48(20): 1036-1039. DOI: 10.12354/j.issn.1000-8179.2021.20210436

地佐辛联合不同药物对腹腔镜胃癌根治术后睡眠质量和早期恢复的影响

Effects of dezocine combined with different drugs on sleep quality and earlypostoperative recovery quality after laparoscopic resection of gastric cancer

  • 摘要:
      目的  观察地佐辛联合不同药物对腹腔镜下胃癌根治术后睡眠质量和早期恢复的影响。
      方法  选取天津医科大学肿瘤医院2020年4月至2020年12月择期全麻下行腹腔镜胃癌根治术患者240例,采用数字表法将患者随机分为4组(每组60例),患者经静脉自控镇痛(patient-controllled intravenous analgesia,PCIA):舒芬太尼组(S组),地佐辛+舒芬太尼组(DS组),地佐辛+氟比洛芬酯组(DF组),地佐辛+右美托咪定组(DD组)。S组为舒芬太尼2.5 µg/kg;DS组为地佐辛0.4 mg/kg+舒芬太尼1.25 µg/kg;DF组为地佐辛0.4 mg/kg+氟比洛芬酯200 mg;DD组为地佐辛0.4 mg/kg+右美托咪定1 µg/kg。于术前1天、术后第1、2、3天行阿森斯失眠量表(athens insomenia scale,AIS)和40项恢复质量(quality of recovery-40,QoR-40)评分。记录术后0~24 h、24~48 h、48~72 h镇痛泵按压次数、补救镇痛次数、不良反应发生情况。
      结果  与S组比较,DF、DD组在术后第1、2天AIS评分明显升高(P<0.05),DF、DD组在术后3天内QoR-40评分明显升高(P<0.05),恶心呕吐、头晕头痛发生率明显下降,皮肤瘙痒未见发生(P<0.05)。
      结论  地佐辛可联合多种药物于腹腔镜下胃癌根治术后,在镇痛效果上与强阿片类药无异,但联合氟比洛芬酯或右美托咪定可改善患者术后睡眠和早期恢复质量,减少不良反应发生。

     

    Abstract:
      Objective  To assess the effects of dezocine combined with different drugs on sleep quality and early postoperative recovery quality after laparoscopic resection of gastric cancer.
      Methods  In total, 240 patients during April 2020 to December 2020 were randomly assigned into four groups for patient-controllled intravenous analgesia (PCIA) from Tianjin Medical University Cancer Institute & Hospital, namely group S, group DS, group DF, and group DD. Group S was administered sulfentanil 2.5 µg/kg; group DS, dezocine 0.4 mg/kg and sulfentanil 1.25 µg/kg; group DF, dezocine 0.4 mg/kg and flurbiprofen 200 mg; and group DD, dezocine 0.4 mg/kg and dexmedetomidine 1 μg/kg. Athens insomenia scale (AIS) and quality of recovery-40 (QoR-40) were evaluated one night preoperatively and first to third nights postoperatively. The self-controlled time and additional time of PCIA were recorded at 0–24 h, 24–48 h, and 48–72 h after surgery, and adverse effects were recorded.
      Results  Compared with group S, sleep quality of groups DF and DD was improved on the first and second nights postoperatively, and the QoR-40 of groups DF and DD was increased 3 days after surgery (P<0.05). The rates of nausea, vomiting, dizziness, and headache were decreased, and pruritus was not noted (P<0.05).
      Conclusions  Compared with opioid drugs, dezocine combined with different drugs showed no difference in terms of providing analgesia for patients undergoing laparoscopic resection of gastric cancer. Dezocine combined with flurbiprofen and dexmedetomidine can improve sleep quality and early postoperative recovery quality after surgery and can decrease adverse effects.

     

/

返回文章
返回